Single award · contract

License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk of…

Award ID: 75A50124C00046

FY2024 · complete year · data as of 2026-07-03

A single federal award, with both ends of the trail linked.

$65.4M
Total award value

Award 75A50124C00046 is a contract from the Department of Health and Human Services, $65.4M obligated, FY2024 to FY2031, for License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk…. The work is performed in California. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC 6505 (Drugs and Biologicals). Source

Description

License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk of Transfusion-Transmitted Infection (TTI) by Recognized, Emerging, Epidemic, and Endemic Pathogens That Is Capable of Treating Over 10 Million RBC Com

Award details

Award typeContract
PIID75A50124C00046
Action date2024
Period84 mo
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
Competed?Not recordedSource
Total (exact)$65,358,564

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.